Lexaria Awards CRO Contract for 12-Week DehydraTECH GLP-1 Chronic Human Study [Yahoo! Finance]
Lexaria Bioscience Corp. (LEXX)
Company Research
Source: Yahoo! Finance
KELOWNA, BC / ACCESSWIRE / June 18, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX,)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces it has now hired a contract research organization (" CRO ") to oversee execution of the Company's 12-week chronic study GLP-1-H24-4, (the " Study ") which will evaluate various DehydraTECH-GLP-1 (glucagon-like peptide) formulations and other treatments with efficacy objectives of weight loss, blood sugar reduction, and more. Study preparations with the CRO have commenced pursuant to an initial start-up agreement under which a number of activities will occur such as full clinical protocol design and writing in consultation with medical experts, regulatory authority submissions, and data management planning. "This Study will be the most comprehensive and impactful GLP-1 investigation that Lexaria has ever undertaken," said John Docherty, President of Lexaria Bioscience Corp. "The greatly expanded scope
Show less
Read more
Impact Snapshot
Event Time:
LEXX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEXX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEXX alerts
High impacting Lexaria Bioscience Corp. news events
Weekly update
A roundup of the hottest topics
LEXX
News
- Lexaria Awards CRO Contract for 12-Week DehydraTECH GLP-1 Chronic Human StudyAccesswire
- Dosing Continues in Lexaria’s Second GLP-1 Human Pilot StudyAccesswire
- Lexaria Awards Contract For Third GLP-1 Human Pilot Study [Yahoo! Finance]Yahoo! Finance
- Lexaria Awards Contract For Third GLP-1 Human Pilot StudyAccesswire
- Lexaria Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy [Yahoo! Finance]Yahoo! Finance
LEXX
Sec Filings
- 6/12/24 - Form EFFECT
- 6/11/24 - Form 424B3
- 6/3/24 - Form S-1
- LEXX's page on the SEC website